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Background: Resistance-nodulation-division (RND) efflux pumps are important mediators of antibiotic resist-
ance. RND pumps, including the principal multidrug efflux pump AcrAB-TolC in Salmonella, are tripartite systems
with an inner membrane RND transporter, a periplasmic adaptor protein (PAP) and an outer membrane factor
(OMF). We previously identified the residues required for binding between the PAP AcrA and the RND transporter
AcrB and have demonstrated that PAPs can function with non-cognate transporters. AcrE and AcrD/AcrF are
homologues of AcrA and AcrB, respectively. Here, we show that AcrE can interact with AcrD, which does not pos-
sess its own PAP, and establish that the residues previously identified in AcrB binding are also involved in AcrD
binding.
Methods: The acrD and acrE genes were expressed in a strain lacking acrABDEF (D3RND). PAP residues involved
in promiscuous interactions were predicted based on previously defined PAP-RND interactions and corresponding
mutations generated in acrA and acrE. Antimicrobial susceptibility of the mutant strains was determined.
Results: Co-expression of acrD and acrE significantly decreased susceptibility of the D3RND strain to AcrD
substrates, showing that AcrE can form a functional complex with AcrD. The substrate profile of Salmonella AcrD
differed from that of Escherichia coli AcrD. Mutations targeting the previously defined PAP-RND interaction sites
in AcrA/AcrE impaired efflux of AcrD-dependent substrates.
Conclusions: These data indicate that AcrE forms an efflux-competent pump with AcrD and thus presents an
alternative PAP for this pump. Mutagenesis of the conserved RND binding sites validates the interchangeability
of AcrA and AcrE, highlighting them as potential drug targets for efflux inhibition.
Introduction
MDR efflux pumps play a major role in antibiotic resistance of bac-
teria by reducing the intracellular concentration of drugs.1,2 The
resistance-nodulation-division (RND) family of efflux pumps confer
clinically relevant antibiotic resistance on Gram-negative bacteria,
such as Salmonella enterica.3–6 Tripartite RND pumps span the
double membrane of Gram-negative bacteria and consist of an
inner membrane RND transporter, a periplasmic adaptor protein
(PAP) and an outer membrane factor (OMF).7–9 The majority
of RND pumps exhibit a broad substrate profile, which includes
multiple classes of antibiotics, biocides, detergents, dyes and
metals.10–12
S. enterica has five RND pumps: AcrAB, AcrD, AcrEF, MdtABC
and MdsABC.5 The AcrAB pump is constitutively expressed in
S. enterica and displays a wide substrate profile, consisting of
multiple classes of antibiotics, bile salts, detergents and dyes.5
The AcrEF system has a similar substrate profile to AcrAB but is
not constitutively expressed.5,13 In S. enterica, AcrB is 80%
identical to AcrF, whereas AcrD is 64% and 65% identical to
AcrB and AcrF, respectively.14,15 This sequence divergence is
reflected in the substrate profile of AcrD, which is narrower than
that of AcrB and AcrF. In Escherichia coli, AcrD has been shown
to export aminoglycosides and anionic b-lactams.16–18
Homology modelling of E. coli AcrD, combined with molecular
dynamic simulations, has also suggested that the different sub-
strate specificities between AcrB and AcrD stem from the corre-
sponding differences in the physicochemical and topological
properties of their binding pockets.19,20 Until now, this view of
AcrD substrate selectivity has been assumed to also apply to
the AcrD pump in S. enterica.
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The RND transporter genes are usually co-located with their
cognate PAP in a single operon. In S. enterica there are four RND-
associated PAPs: AcrA, AcrE, MdtA and MdsA.5 Based on sequence
analyses and structural alignments, AcrA and AcrE are the most
closely related, with an amino acid sequence identity of 69.3%
(Figure 1a). The predicted secondary structure of AcrA and AcrE is
nearly identical to that of the experimentally determined structure
of AcrA from E. coli (Figure 1b).21 Both MdtA and MdsA are more se-
quentially divergent, with MdsA sharing less than 30% identity
with AcrA and AcrE, which is predicted to translate into significant
differences in the 3D structure.5
Although AcrA is the cognate PAP for AcrB, the RND pump AcrD
was shown to depend on AcrA to form a functional tripartite efflux
system since it lacks an associated PAP-encoding gene.22 Indeed,
AcrA has been reported to also function with AcrF in E. coli23 and
recently, AcrE has been demonstrated to function with AcrB in
S. enterica serovar Typhimurium.21 The major RND transporter-
binding residues of AcrA have been highlighted by cryogenic
electron microscopy structural studies8,9 and validated by muta-
genesis.21 Our comparative analysis of Salmonella PAPs demon-
strated that these critical residues fall within a discrete number of
linear sequence sites, which we termed RND-binding boxes.21
These are shared between AcrA and AcrE, potentially explaining
their interchangeability21 but are not shared between MdtA and
MdsA, explaining their inability to function with non-cognate RND
transporters.21 Although AcrA and AcrE have been shown to be
largely interchangeable, the ability of AcrE to function with AcrD
remains unknown.
Here, we have investigated the substrate specificity of
S. Typhimurium SL1344 AcrD. We furthermore explored whether
the interoperability of AcrA and AcrE extends to the RND transport-
er AcrD and whether this interaction is driven by the same residues




All strains used in this study are listed in Table 1. The S. Typhimurium strains
were derived from the WT strain SL1344, a pathogenic strain first isolated
from an experimentally infected calf.24 All strains were grown in LB broth at
37C with aeration.
Construction of gene deletion mutants
The DacrB mutant strain was constructed previously.25 All other mutant
strains were constructed using the k red recombinase system described
previously, antibiotic markers were removed, and the process repeated to
make double- and triple-knockout S. Typhimurium SL1344 strains (Table
1).26 All the primers used for generating gene knockouts and cloning are
listed in Table S1, available as Supplementary data at JAC Online.
Plasmid construction
All plasmids used in this study are listed in Table 1. The acrD and acrA genes
were amplified from S. Typhimurium SL1344 by PCR and cloned into
pHSG398 and pACYC177 plasmids, respectively, as described previously.22
Expression of the acrE gene is repressed by H-NS.13 Therefore, to clone acrE
into pACYC177 and obtain sufficient expression, a forward primer was
designed containing the trc promoter and the acrE ribosomal binding site
(Table S1). The synthetic trc promoter is derived from the E. coli trp and
lacUV5 promoters, driving a high level of transcription.27
The acrE gene was amplified from S. Typhimurium SL1344 genomic
DNA by PCR using the acrE cloning F and R primers (Table S1), which intro-
duced ScaI and BamHI sites, respectively. The PCR fragment contained
the trc promoter and a region 14 bp upstream to 2 bp downstream of acrE.
This fragment was digested with ScaI and BamHI and cloned into the corre-
sponding sites of pACYC177, where an ampicillin resistance gene was
located. The resulting plasmid pACYC177 acrE solely possessed a kanamy-
cin resistance marker. The control pACYC177KanR plasmid was constructed
as described previously.22
Construction of mutant pacrA and pacrE plasmids
The acrA and acrE point mutants were generated using the GeneArts
R
Gene
Synthesis Service (Invitrogen, Germany) and subsequently cloned into the
pACYC177 plasmid using the Subcloning Service (Invitrogen). All plasmids
were sequenced to check for the presence of the desired point mutations
and to ensure there were no unwanted secondary mutations.
Determination of antimicrobial susceptibility
The MICs of various antimicrobials were determined using the agar dilution
method according to CLSI guidance.28
Results and discussion
AcrD of S. Typhimurium SL1344 does not transport
aminoglycosides
Despite being isolated several decades ago,29 the substrate specifi-
city of AcrD remains relatively poorly characterized experimentally.
Therefore, an additional rationale of this study was to investigate
the substrate specificity of S. Typhimurium SL1344 AcrD, especially
in the context of PAP-RND interactions, which may provide modu-
latory effects on the specificity of the pump. Previously, it has been
reported that E. coli AcrD exports aminoglycosides.17,18 However,
there is a lack of experimental evidence in Salmonella and most of
the features of Salmonella AcrD are inferred, based on close
sequence similarity to E. coli AcrD (97.4%; Figure S1). While some
previous work has addressed this, aminoglycosides have not
been specifically investigated.5,15 Therefore, we investigated the
substrate range of AcrD in S. Typhimurium SL1344.
The DacrD SL1344 strain did not exhibit any significant increase
in susceptibility to any of the antimicrobials tested, as previously
reported.15 This is likely because expression of acrD is generally low
in laboratory conditions and, for many compounds, any effect
would be masked by the presence of AcrB.15 Therefore, pacrD
was transformed into the DacrB strain, and the effect of acrD
overexpression on antimicrobial susceptibility of the resulting
transformant was determined. The DacrB/pacrD strain displayed
significantly increased MIC values of reported AcrD substrates az-
treonam, carbenicillin, cloxacillin, fusidic acid, nafcillin, novobiocin
and oxacillin (Table 2), consistent with previous studies,22 suggest-
ing that protein is functionally expressed and incorporated into the
membrane. Surprisingly, the introduction of acrD into the DacrB
(DacrB/pacrD) strain did not result in a significant increase in MICs
of the aminoglycosides kanamycin, gentamicin, spectinomycin
or streptomycin (Table 2), implying that AcrD is not measurably
contributing to aminoglycoside efflux. This is in contrast to the








/jac/advance-article/doi/10.1093/jac/dkab237/6323550 by guest on 19 July 2021
Figure 1. (a) A pairwise sequence alignment of AcrA and AcrE of S. enterica highlighting their predicted close structural homology. The top second-
ary structure is derived from the previously reported homology model of AcrE,21 while the bottom secondary structure corresponds to the experi-
mental AcrA structure from E. coli (PDB ID 5O66; chain G), which has no sequence gaps with the AcrA of S. enterica. (b) Mapping the sequence
differences between the Salmonella AcrE and AcrA onto the homology model of the AcrE.21 The non-conserved substitutions are shown in side-
chain and semi-transparent sphere representation. The mapping demonstrates that the bulk of the discrepancies, which may be expected to ac-
count for the functional differences between the PAPs, map to their b-barrel and membrane-proximal domains. This figure appears in colour in the
online version of JAC and in black and white in the print version of JAC.







/jac/advance-article/doi/10.1093/jac/dkab237/6323550 by guest on 19 July 2021
wherein deletion of acrD was shown to decrease aminoglyco-
side MICs 2- to 8-fold17 and expression of acrD from a plasmid
in an acrB::aph DacrD strain increased aminoglycoside MICs
2-fold.30 In agreement with our findings, the AcrD efflux pump
of the Gram-negative plant pathogen Erwinia amylovora
has also been reported to not play a role in aminoglycoside
resistance.31
A possible explanation for the differences in the substrate pro-
files of AcrD between E. coli and S. Typhimurium could be the
observed discrepancy between the residues in their respective
access and deep binding pockets (Figure S1). Due to the lack of ex-
perimental AcrD structure, the functional significance of the resi-
dues of the respective drug-binding pockets of AcrD is inferred
from their positional homology with corresponding AcrB residues,
structures of which have been experimentally defined for both
E. coli32–34 and more recently for Salmonella.35 Specifically, the
presence of a serine in the deep binding pocket of S. Typhimurium
AcrD at position 610, which in E. coli AcrD is occupied by an alanine,
could possibly impact the previously described lipophilic character
of the drug-binding cavity.20 There are also two additional discrep-
ancies, which could be seen as non-conservative substitutions,
namely that of E. coli AcrD isoleucine to phenylalanine at position
633 (I633F) in S. Typhimurium, and leucine to glutamine at
position 565 (L565Q), both of which are likely to cause steric
hinderance and impact the electrostatics of the access binding
pocket, respectively.19,20 These subtle differences may account for
the notable differences in substrate recognition by AcrD between
the two species.
Table 1. List of S. Typhimurium strains and plasmids used in this study
Strain/plasmid Genotype/characteristic Source/reference
Strains
SE01 WT S. Typhimurium SL1344 24
SE02 DacrB 25
SE446 DacrB/pHSG398 This study
SE449 DacrB/pacrD This study
SE379 DacrD This study
SE502 DacrABDacrDDacrEF (D3RND) This study
SE544 D3RND/pHSG398 This study
SE545 D3RND/pACYC177KanR This study
SE507 D3RND/pacrD This study
SE510 D3RND/pacrA This study
SE511 D3RND/pacrE This study
SE506 D3RND/pACYC177KanR!pHSG398 This study
SE548 D3RND/pACYC177KanR!pacrD This study
SE508 D3RND/pacrD!pacrA This study
SE509 D3RND/pacrD!pacrE This study
SE546 D3RND/pHSG398!pacrA This study
SE547 D3RND/pHSG398!pacrE This study
SE553 D3RND/pHSG398! F292G AcrA This study
SE554 D3RND/pHSG398!G363F AcrA This study
SE554 D3RND/pHSG398! F291G AcrE This study
SE556 D3RND/pHSG398!G362F AcrE This study
SE557 D3RND/pacrD! F292G AcrA This study
SE558 D3RND/pacrD!G363F AcrA This study
SE559 D3RND/pacrD! F291G AcrE This study
SE560 D3RND/pacrD!G362F AcrE This study
Plasmids
pACYC177 vector; AmpR, KanR ATCC
pACYC177KanR vector; KanR This study
pHSG398 vector; ChlR Takara Bio Group
pacrA SL1344 acrA gene cloned into pACYC177; KanR This study
pacrE SL1344 acrE gene cloned into pACYC177; KanR This study
pacrD SL1344 acrD gene cloned into pHSG398; ChlR This study
F292G AcrA SL1344 acrA gene with an F292G point mutation cloned into pACYC177; KanR This study
G363F AcrA SL1344 acrA gene with a G363F point mutation cloned into pACYC177; KanR This study
F291G AcrE SL1344 acrE gene with an F291G point mutation cloned into pACYC177; KanR This study
G362F AcrE SL1344 acrE gene with a G362F point mutation cloned into pACYC177; KanR This study
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AcrE forms a functional PAP-RND pair with AcrD
AcrD has been previously shown to depend on AcrA to function as
an efflux system.22 Therefore, owing to the high similarity of the
predicted RND-binding sites between the PAPs AcrA and AcrE,21,36
we hypothesized that AcrE should also function with AcrD. To test
this, we deleted the acrAB, acrD and acrEF genes in S. Typhimurium
SL1344 to create a strain without active RND-dependent efflux, as
indicated by significantly increased susceptibility to AcrB, AcrF and
AcrD substrates (Table 2 and Table S2). The MdtABC and MdsABC
systems are much less similar to the three AcrB/AcrD/AcrF-based
systems and play a minor role in resistance. Consistent with this,
they are not expressed under standard laboratory conditions5 and,
furthermore, their inactivation did not have any additive effect on
antimicrobial susceptibility.5,21 Hence, these systems were not
inactivated.
Firstly, we validated the previously reported AcrA dependency
of AcrD in S. Typhimurium SL1344.22 The pacrA and pacrD plasmids
were co-transformed into the D3RND strain and the antimicrobial
susceptibility of the resulting transformant was determined. We
found that co-expression of acrA and acrD in the D3RND strain
significantly decreased susceptibility to known AcrD substrates
aztreonam, carbenicillin, cloxacillin, fusidic acid, nafcillin, novobio-
cin, oxacillin and ticarcillin (Table 2).
Secondly, to determine whether AcrE and AcrD form a func-
tional complex together, pacrD and pacrE were co-transformed
into the D3RND strain and the susceptibility to validated AcrD
substrates was tested. Co-expression of acrE and acrD in the
D3RND strain significantly increased the MICs of aztreonam,
carbenicillin, cloxacillin, fusidic acid, nafcillin, novobiocin,
oxacillin and ticarcillin (Table 2). There was no difference in MIC
values between co-expressing acrD with acrA or acrE, which
demonstrates the full interchangeability of the two PAPs (Table
2). Furthermore, co-expression of either acrE and acrD or acrA
and acrD in the D3RND strain did not increase MIC values of the
tested AcrB substrates (i.e. acriflavine, crystal violet, ethidium
bromide, erythromycin, methylene blue, rhodamine 6G and
tetracycline),5 clearly showing AcrD-mediated efflux (Table S2).
Overexpression of either acrD or acrE alone in the D3RND strain
did not significantly increase MIC values of the AcrD substrates
tested (Table 2), signifying that AcrE requires the presence of
AcrD to form a functional, efflux-competent complex.
Table 2. Susceptibility of S. Typhimurium strains to antimicrobials
Strain
MIC (mg/L)
ATM CAR CXA FA NAF NOV OXA TIC GEN SPT STR KAN
WT SL1344 0.06 4 512 1024 1024 512 512 4 0.5 16 8 1
DacrB 0.06 1 4 4 8 2 4 1 0.25 16 8 1
DacrB/pHSG398 0.06 1 4 4 8 2 2 1 0.25 16 4 1
DacrB/pacrD 0.25 8 16 64 64 8 16 16 0.25 16 4 1
DacrD 0.06 4 512 1024 1024 512 512 4 0.5 16 4 1
DacrABDacrDDacrEF (D3RND) 0.06 1 1 4 2 1 1 1 0.25 16 4 1
D3RND/pHSG398 0.06 0.5 1 4 2 1 1 1 0.25 16 4 1
D3RND/pACYC177KanR 0.06 1 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pacrD 0.06 0.5 1 4 2 1 1 1 0.25 16 4 1
D3RND/pacrA 0.06 1 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pacrE 0.06 1 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pACYC177KanR!pHSG398 0.06 0.5 1 4 2 1 1 1 0.25 16 8 >32
D3RND/pACYC177KanR!pacrD 0.06 1 1 4 2 1 1 1 0.25 16 4 >32
D3RND/pacrD!pacrA 0.25 8 16 128 32 8 16 8 0.5 16 4 >32
D3RND/pacrD!pacrE 0.25 8 16 128 32 8 16 8 0.5 16 4 >32
D3RND/pHSG398!pacrA 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pHSG398!pacrE 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pHSG398! F292G AcrA 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pHSG398!G363F AcrA 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pHSG398! F291G AcrE 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pHSG398!G362F AcrE 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pacrD! F292G AcrA 0.06 0.5 1 4 2 1 1 1 0.5 16 4 >32
D3RND/pacrD!G363F AcrA 0.06 1 1 4 2 1 1 1 0.25 16 4 >32
D3RND/pacrD! F291G AcrE 0.06 0.5 1 4 2 1 1 1 0.25 16 4 >32
D3RND/pacrD!G362F AcrE 0.06 1 1 4 2 1 1 1 0.25 16 4 >32
ATM, aztreonam; CAR, carbenicillin; CXA, cloxacillin; FA, fusidic acid; GEN, gentamicin; KAN, kanamycin; NAF, nafcillin; NOV, novobiocin; OXA, oxacillin;
SPT, spectinomycin, STR, streptomycin, TIC, ticarcillin. Values in bold indicate a significant increase (>2-fold) compared with those of their correspond-
ing parental strains.
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Our data suggest interchangeability between AcrA and AcrE in
S. Typhimurium SL1344. One possible explanation for the inter-
operability between AcrA and AcrE is that the latter may function
as a backup PAP for when AcrA function is impaired or lost. This
idea is supported by evidence from studies demonstrating that in
S. Typhimurium, in the absence of acrA, it was possible to select for
acrE overexpression.21,37 Another study demonstrated that in the
absence of acrA and acrE, it is possible to restore the phenotypic
defect in active efflux by complementing with either acrA or
acrE.36
Disruption of the RND-binding residues in AcrA or AcrE
impairs AcrD-mediated efflux of substrate drugs
AcrE has been shown to complement AcrA and is capable of inter-
acting with AcrB.38 Recently, we showed that this promiscuity be-
tween Salmonella AcrA and AcrE stems from the highly conserved
RND-binding sites (termed RND-binding boxes) between these two
PAPs.21 Specifically, within the Salmonella AcrA, we identified sev-
eral residues mapping to the b-barrel and membrane proximal
domains that were important for AcrB binding.21 There, the disrup-
tion of the F292 or G363 residues in AcrA produced the most pro-
nounced phenotypic effect, resulting in severely abrogated active
efflux and significantly increased susceptibility to AcrB sub-
strates.21 Therefore, to investigate whether these residues are also
important for binding of the newly determined cognate PAPs to
AcrD, the point mutations corresponding to F292G or G363F were
constructed in both pacrA and pacrE (F291G and G362F, respect-
ively) and co-transformed with pacrD into the D3RND strain. Based
on structural analysis, we chose F292G and G363F as target muta-
tions due to their radical change of respective sidechain properties.
Consistent with the data obtained in co-expression with AcrB,21
the disruption of F292 or G363 in AcrA resulted in impaired AcrD-
mediated efflux of AcrD substrates, confirming that the same resi-
dues required for binding of AcrA to AcrB are also required for its
binding to AcrD (Table 2). These point mutations do not impact the
protein levels and folding, as previously demonstrated.21 To deter-
mine whether the corresponding residues in AcrE are also import-
ant for AcrD binding, F291 and G362 were mutated (Figure S2). As
expected, the F291G or G362F point mutations in AcrE also
impaired AcrD-mediated efflux in the D3RND strain (Table 2).
These data suggest that the PAP-RND binding sites previously iden-
tified based upon AcrA-AcrB interaction are indeed both sequen-
tially and functionally conserved between AcrA and AcrE and
account for the productive recognition and formation of functional
tripartite pumps.
Conclusions
Here, we report that the PAP AcrE can form a functional complex
with the RND transporter AcrD, further validating the interchange-
ability between the homologous PAPs AcrA and AcrE. Furthermore,
this interchangeability is likely to be due to the highly conserved
and specific RND-binding sites between these two PAPs. Our report
highlights that the redundancy between these two PAPs must be
taken into account when targeting them for efflux inhibition.
Therefore, the residues we identified here could inform future de-
sign of effective efflux inhibitors targeting PAPs or tripartite com-
plex assemblies.
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